JPWO2022244447A1 - - Google Patents

Info

Publication number
JPWO2022244447A1
JPWO2022244447A1 JP2023522277A JP2023522277A JPWO2022244447A1 JP WO2022244447 A1 JPWO2022244447 A1 JP WO2022244447A1 JP 2023522277 A JP2023522277 A JP 2023522277A JP 2023522277 A JP2023522277 A JP 2023522277A JP WO2022244447 A1 JPWO2022244447 A1 JP WO2022244447A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023522277A
Other languages
Japanese (ja)
Other versions
JP7533830B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022244447A1 publication Critical patent/JPWO2022244447A1/ja
Priority to JP2024052694A priority Critical patent/JP7586361B2/ja
Application granted granted Critical
Publication of JP7533830B2 publication Critical patent/JP7533830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023522277A 2021-05-17 2022-03-22 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物 Active JP7533830B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024052694A JP7586361B2 (ja) 2021-05-17 2024-03-28 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021083347 2021-05-17
JP2021083347 2021-05-17
PCT/JP2022/013051 WO2022244447A1 (ja) 2021-05-17 2022-03-22 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024052694A Division JP7586361B2 (ja) 2021-05-17 2024-03-28 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物

Publications (2)

Publication Number Publication Date
JPWO2022244447A1 true JPWO2022244447A1 (https=) 2022-11-24
JP7533830B2 JP7533830B2 (ja) 2024-08-14

Family

ID=84141538

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023522277A Active JP7533830B2 (ja) 2021-05-17 2022-03-22 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物
JP2024052694A Active JP7586361B2 (ja) 2021-05-17 2024-03-28 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024052694A Active JP7586361B2 (ja) 2021-05-17 2024-03-28 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物

Country Status (6)

Country Link
US (1) US20240252559A1 (https=)
EP (2) EP4700115A2 (https=)
JP (2) JP7533830B2 (https=)
CN (1) CN117279521A (https=)
TW (1) TW202313077A (https=)
WO (1) WO2022244447A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11228425A (ja) * 1998-02-13 1999-08-24 Takeda Food Products Ltd Ｉｌ−１２産生誘導組成物
JP2010095465A (ja) * 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
JP2015096476A (ja) * 2013-11-15 2015-05-21 株式会社東洋新薬 コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物
JP2017114814A (ja) * 2015-12-24 2017-06-29 丸善製薬株式会社 化粧料
WO2019045037A1 (ja) * 2017-09-01 2019-03-07 ハウスウェルネスフーズ株式会社 ヒアルロン酸産生促進用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5207313B2 (ja) 2008-05-30 2013-06-12 有限会社バイオメディカルリサーチグループ 乳酸菌配合物及びその製造方法
JP2010235534A (ja) 2009-03-31 2010-10-21 Fancl Corp 骨粗鬆症の予防又は治療用剤
KR101402926B1 (ko) * 2012-05-25 2014-06-03 한국 한의학 연구원 황련해독탕의 유산균 발효물을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학적 조성물 및 건강기능식품
KR101554875B1 (ko) * 2015-01-09 2015-09-24 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물
KR20160086249A (ko) * 2015-07-27 2016-07-19 (주) 와이디생명과학 락토바실러스 플란타룸 yd-212 균주 및 이를 이용하여 제조되는 발효물을 포함하는 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11228425A (ja) * 1998-02-13 1999-08-24 Takeda Food Products Ltd Ｉｌ−１２産生誘導組成物
JP2010095465A (ja) * 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
JP2015096476A (ja) * 2013-11-15 2015-05-21 株式会社東洋新薬 コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物
JP2017114814A (ja) * 2015-12-24 2017-06-29 丸善製薬株式会社 化粧料
WO2019045037A1 (ja) * 2017-09-01 2019-03-07 ハウスウェルネスフーズ株式会社 ヒアルロン酸産生促進用組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
木元広実: "Lactococcus lactis H61 の老化抑制効果と作用機構の解明に向けて", 日本乳酸菌学会誌, vol. 29(2), JPN6022022772, 2018, pages 69 - 78, ISSN: 0005249976 *

Also Published As

Publication number Publication date
EP4342535A1 (en) 2024-03-27
EP4342535A4 (en) 2025-04-23
JP2024075769A (ja) 2024-06-04
EP4700115A2 (en) 2026-02-25
JP7586361B2 (ja) 2024-11-19
CN117279521A (zh) 2023-12-22
JP7533830B2 (ja) 2024-08-14
TW202313077A (zh) 2023-04-01
US20240252559A1 (en) 2024-08-01
WO2022244447A1 (ja) 2022-11-24

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
JPWO2022244447A1 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230824

A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20230920

A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20231120

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20231121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240702

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240716

R150 Certificate of patent or registration of utility model

Ref document number: 7533830

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150